title: Metabolic syndrome, platelet activation and the development of transient ischemic attack or thromboembolic stroke.
abstract: Stroke is the second most common cause of mortality in the world today, where transient ischemic attack (TIA) is a period of focal ischemia, the symptoms of which resemble a thromboembolic stroke. Contrary to stroke, TIA symptoms typically last less than one hour and necrosis is absent. Stroke is often preceded by TIA, making it an important predictor of future ischemic events. The causal role of atherosclerosis in the development of TIA is well established, however, research indicates that the atherosclerotic process begins years earlier with the development of metabolic syndrome, which affects approximately 45% of the adult population worldwide. Metabolic syndrome is present if three or more of the following is present: increased waist circumference, increased triglycerides, decreased HDL, increased fasting glucose and hypertension. This syndrome causes systemic inflammation that activates the coagulation system and may cause the formation of pathological thrombi. The role of platelets in stroke has been studied and platelet activation pathways identified. ADP and thromboxane A(2) are the most common activators of platelets in normal physiology. Several pharmacological treatments have been employed to prevent the activation of platelets, the most common of which include aspirin and P2Y(12)-inhibitors. Although treatment is administered strokes and subsequent TIAs are very common in individuals that suffered an initial event. This indicates that research needs to be done in order to elucidate new therapeutic targets, but also to better treat ischemic events to not only decrease the amount of recurring events but also decrease stroke mortality worldwide.
authors.affiliation: Department of Physiology, Faculty of Health Sciences, University of Pretoria, Arcadia 0007, South Africa.
authors.forename: Mia-Jeanne
authors.initials: MJ
authors.lastname: van Rooy
authors.affiliation: Department of Physiology, Faculty of Health Sciences, University of Pretoria, Arcadia 0007, South Africa. Electronic address: resia.pretorius@up.ac.za.
authors.forename: Etheresia
authors.initials: E
authors.lastname: Pretorius
mesh_terms: D000818:Animals; D050197:Atherosclerosis / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D001792:Blood Platelets / Q000187:drug effects / Q000473:pathology; D006801:Humans; D002546:Ischemic Attack, Transient / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D024821:Metabolic Syndrome / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D015539:Platelet Activation / Q000187:drug effects; D020521:Stroke / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology
keywords: Metabolic syndrome; Platelet activation pathway; Stroke; Transient Ischemic attack